A
Allergy Asthma Research Institute | Waco, TX
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
azelastine hydrochloride
BLU-5937
fluticasone propionate
Fluticasone Propionate
Lebrikizumab
Diphenhydramine
Azelastine Hydrochloride
azelastine Hcl
Symbicort®
S-600918
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 21 total trials
This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).
Enrolling
Refractory Chronic Cough
Drug: BLU-5937
Drug: Placebo
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. The stu...
Enrolling
Perennial Allergic Rhinitis (PAR)
Drug: Placebo
Drug: LY3650150
Trial sponsors
N
B
B
B
F
K
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems